CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition

Conditions:   Kidney Cancer;   Renal Cell Carcinoma Interventions:   Drug: Cabozantinib;   Drug: Nivolumab;   Procedure: Cytoreductive nephrectomy Sponsors:   Mark Stein;   Exelixis;   Bristol-Myers Squibb Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials